Bueno, H., Armstrong, P. W., Buxton, M. J., Danchin, N., Lubsen, J., Roland, E., … Cardiovascular Round Table Clinical Trials ThinkTank participants, . (2011). The future of clinical trials in secondary prevention after acute coronary syndromes. Eur Heart J, 32(13), 1583–1589. https://doi.org/10.1093/eurheartj/ehq388

Bueno, Héctor, Paul W. Armstrong, Martin J. Buxton, Nicolas Danchin, Jacobus Lubsen, Edmond Roland, Freek W. Verheugt, et al. “The future of clinical trials in secondary prevention after acute coronary syndromes.” Eur Heart J 32, no. 13 (July 2011): 1583–89. https://doi.org/10.1093/eurheartj/ehq388.

Bueno H, Armstrong PW, Buxton MJ, Danchin N, Lubsen J, Roland E, et al. The future of clinical trials in secondary prevention after acute coronary syndromes. Eur Heart J. 2011 Jul;32(13):1583–9.

Bueno, Héctor, et al. “The future of clinical trials in secondary prevention after acute coronary syndromes.” Eur Heart J, vol. 32, no. 13, July 2011, pp. 1583–89. Pubmed, doi:10.1093/eurheartj/ehq388.

Bueno H, Armstrong PW, Buxton MJ, Danchin N, Lubsen J, Roland E, Verheugt FW, Zalewski A, Jackson N, Komajda M, Steg PG, Cardiovascular Round Table Clinical Trials ThinkTank participants. The future of clinical trials in secondary prevention after acute coronary syndromes. Eur Heart J. 2011 Jul;32(13):1583–1589.